ondansetron has been researched along with Ovarian Hyperstimulation Syndrome in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Ovarian Hyperstimulation Syndrome: A complication of OVULATION INDUCTION in infertility treatment. It is graded by the severity of symptoms which include OVARY enlargement, multiple OVARIAN FOLLICLES; OVARIAN CYSTS; ASCITES; and generalized EDEMA. The full-blown syndrome may lead to RENAL FAILURE, respiratory distress, and even DEATH. Increased capillary permeability is caused by the vasoactive substances, such as VASCULAR ENDOTHELIAL GROWTH FACTORS, secreted by the overly-stimulated OVARIES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakırcı, Ş | 1 |
| Sağsöz, N | 1 |
| Devrim, T | 1 |
| Şahin, Y | 1 |
| Bulanık, M | 1 |
| Gözüyukarı, H | 1 |
1 other study available for ondansetron and Ovarian Hyperstimulation Syndrome
| Article | Year |
|---|---|
Effect of ondansetron for preventing of ovarian hyperstimulation syndrome: in an experimental rat model.
Topics: Animals; Cabergoline; Dopamine Agonists; Endothelial Cells; Female; Humans; Ondansetron; Ovarian Hyp | 2022 |